Qritive at a Glance: Advancing Global Pathology with AI

Watch the video for a quick overview of Qritive’s mission, technology, and impact in digital pathology.

Singapore, September 12, 2024 — Qritive is transforming the field of digital pathology by delivering AI-powered solutions that improve diagnostic accuracy, efficiency, and accessibility across the globe. Our comprehensive platform brings together powerful diagnostic modules, an advanced image management system, and seamless workflow integration—all designed to support pathologists and healthcare providers in delivering timely, confident decisions.

With a presence in multiple regions and collaborations with leading institutions, Qritive is at the forefront of innovation in pathology AI, helping healthcare systems scale diagnostic capabilities and improve patient outcomes.

About Qritive

Qritive, headquartered in Singapore with operations in the US and India, is transforming digital pathology through advanced AI-powered solutions that support cancer diagnosis and improve health outcomes.

By leveraging cutting-edge deep learning technology, Qritive supports pathologists in the interpretation of pathology assessments and enhances pathology workflows—enabling faster, more accurate diagnoses and reducing time to treatment.

Qritive is committed to empowering healthcare professionals around the world with tools that promote collaboration and high performance, regardless of complexity or distance.

Get in Touch

Want to learn more about our solutions or explore potential collaborations?

Visit www.qritive.com or contact us at info@qritive.com.